JC
AVDL

JBF Capital’s Avadel Pharmaceuticals AVDL Stock Holding History

JBF Capital’s Portfolio AVDL Stock Details AVDL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-40,000
Closed -$862K – 117
2025
Q4 		$862K Buy
+40,000
New +$777K 0.12% 35

Other funds holding AVDL

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

JBF Capital's AVDL Position: Q1 2026 in Review

JBF Capital sold out of Avadel Pharmaceuticals (AVDL) in Q1 2026, closing a stake of 40,000 shares — an estimated $862K sold.

JBF Capital first reported a position in AVDL in Q4 2025 and held it in 1 quarter. The position peaked at $862K in Q4 2025. 2 funds tracked by Wall St. Rank hold AVDL as of Q1 2026.

  • JBF Capital reported no remaining Avadel Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • JBF Capital sold 40,000 Avadel Pharmaceuticals shares in Q1 2026, an estimated $862K.
  • JBF Capital first reported a position in Avadel Pharmaceuticals in Q4 2025 and held it in 1 quarter.
  • JBF Capital's Avadel Pharmaceuticals position peaked at $862K in Q4 2025.
  • 2 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q1 2026.

Based on JBF Capital's 13F filing for Q1 2026, filed 8 May 2026.